Cline Scientific: Initial scientific results in stem cell project
Mölndal, Sweden 2020-03-02
Cline Scientific (Spotlight Stock Market: CLINE B), a world leader in nanotechnology used for cancer diagnostics and stem cell therapies, submits for publication promising scientific results from the stem cell project.
The work behind the scientific article was performed in collaboration with a researcher at Sahlgrenska University Hospital and University of Gothenburg. The results obtained describes how Cline's technology, in combination with specific biomolecules, has the ability to control stem cell differentiation with high precision.
Cline's R&D collaboration with the academy has now resulted in a both a scientific article and data included in a patent application. Further results in this area are pending.
“We are proud and happy to have gotten this far with our stem cell project. It has been hard work for a long time that now pays off. Publications and patents are important parts in the workflow and marks a clear step forward on the journey." Hanne Evenbratt, Product Development Manager.
Cline Scientific AB
431 53 Mölndal
Cline Scientific develops advanced cancer diagnostics and regenerative medicine treatments. The company is working heavily with R&D through joint collaborations with pharmaceutical companies and academic researchers around the world. The focus is on projects in the cancerdiagnostic and stem cell therapy fields since Clines nanotechnology here provides unmet solutions to critical challenges and functions. The unique patented surface nanotechnology is used in cell-based products and processes to drive projects within Life Science into and through the clinical phase.
Cline operates out of Gothenburg, Sweden and was founded in 2012 from a long term research project in surface nanotechnology